Antibody response to purified chick embryo cell vaccine in equines for production of equine rabies immune globulin

被引:3
|
作者
Goel, SK [1 ]
Sharma, S [1 ]
Singh, US [1 ]
机构
[1] Cent Res Inst, Kasauli 173204, India
关键词
PCECV (Rabipur); ERIG; PET;
D O I
10.1016/S1045-1056(03)00059-9
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Rabies is endemic in India. The post exposure treatment of class three bite cases, as recommended by the World Health Organization, must involve the use of rabies immunoglobulin as soon as possible and up to the seventh day of start of anti rabies vaccination. The annual requirement in India as projected by the Ministry of Health, Government of India is about 1500 liters of purified anti rabies serum (ERIG). Central Research Institute (CRI), Kasauli, being the sole producer of ERIG in India, an effort was made to increase the production of ERIG by the use of tissue culture vaccine (Human) for primary immunization of equines. It also involved changing the vaccine from horse brain suspension to tissue culture vaccine by eliminating horse sacrifice for antigen preparation. A better immune response was obtained. (C) 2003 The International Association for Biologicals. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:233 / 236
页数:4
相关论文
共 50 条
  • [31] PURIFIED CHICK-EMBRYO CELL RABIES VACCINE - ECONOMICAL MULTISITE INTRADERMAL REGIMEN FOR POST-EXPOSURE PROPHYLAXIS
    SUNTHARASAMAI, P
    WARRELL, MJ
    VIRAVAN, C
    CHANTHAVANICH, P
    LOOAREESUWAN, S
    SUPAPOCHANA, A
    SUPANARANOND, JKW
    CHITTAMAS, S
    BIJOK, U
    WARRELL, DA
    EPIDEMIOLOGY AND INFECTION, 1987, 99 (03): : 755 - 765
  • [32] PURIFIED CHICK-EMBRYO-CELL (PCEC) RABIES VACCINE - ITS POTENCY PERFORMANCE IN DIFFERENT TEST SYSTEMS AND IN HUMANS
    BARTH, R
    FRANKE, V
    MULLER, H
    WEINMANN, E
    VACCINE, 1990, 8 (01) : 41 - 48
  • [33] Safety and Immunogenicity of purified chick embryo cell rabies vaccine (VaxiRab N) administered intradermally as post exposure prophylaxis
    Ravish, Hardanahalli S.
    Vijayashankar, Veena
    Madhusudana, Shampur N.
    Sudarshan, Mysore K.
    Narayana, Doddabele H. A.
    Andanaiah, Gangaboraiah
    Ashwin, Belludi Y.
    Rachana, Annadani R.
    Shamanna, Manjula
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (08) : 2433 - 2437
  • [34] POST EXPOSURE STUDIES WITH HUMAN-DIPLOID CELL RABIES VACCINE AND PURIFIED CHICK-EMBRYO CELL VACCINE - COMPARATIVE SEROLOGICAL RESPONSES IN MAN
    MADHUSUDANA, SN
    TRIPATHI, KK
    ZENTRALBLATT FUR BAKTERIOLOGIE-INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY VIROLOGY PARASITOLOGY AND INFECTIOUS DISEASES, 1989, 271 (03): : 345 - 350
  • [35] WESTERN EQUINE ENCEPHALOMYELITIS VACCINE PRODUCED IN CHICK EMBRYO CELL CULTURES
    ROBINSON, DM
    BERMAN, S
    LOWENTHAL, JP
    HETRICK, FM
    APPLIED MICROBIOLOGY, 1966, 14 (06) : 1011 - +
  • [36] Evaluation of two intradermal vaccination regimens using purified chick embryo cell vaccine for post-exposure prophylaxis of rabies
    Madhusudana, SN
    Anand, NP
    Shamsundar, R
    NATIONAL MEDICAL JOURNAL OF INDIA, 2001, 14 (03): : 145 - 147
  • [37] IMMUNE-RESPONSE IN PRIMATES VACCINATED WITH DUCK EMBRYO CELL-CULTURE RABIES VACCINE
    LAVENDER, JF
    APPLIED MICROBIOLOGY, 1973, 25 (03) : 327 - 331
  • [38] Safety and neutralizing rabies antibody in healthy subjects given a single dose of rabies immune globulin caprylate/chromatography purified
    Hanna, Kim
    Cruz, Maria Cristina
    Mondou, Elsa
    Corsi, Edward
    Vandeberg, Peter
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2018, 10 : 79 - 88
  • [39] Safety review of the purified chick embryo cell rabies vaccine: Data from the Vaccine Adverse Event Reporting System (VAERS), 1997-2005
    Dobardzic, Azra
    Izurieta, Hector
    Woo, Emily Jane
    Iskander, John
    Shadomy, Sean
    Rupprecht, Charles
    Ball, Robert
    Braun, M. Miles
    VACCINE, 2007, 25 (21) : 4244 - 4251
  • [40] Pre-exposure prophylaxis against rabies in children Safety of purified chick embryo cell rabies vaccine (Vaxirab N) when administered by intradermal route
    Ravish, Haradanahalli S.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2014, 10 (02) : 319 - 320